HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
04 avr. 2024 07h30 HE
|
Avricore Health Inc.
Avriciore's HelathTab platform for point-of-care testing in pharmacy expands Rexall locations.
Health Monitor Appoints Lorraine Forster as SVP, Human Resources, Galvanizing Growth
07 mars 2024 09h08 HE
|
Health Monitor Network
Montvale, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- Pioneering healthcare communications company Health Monitor Network today announced the appointment of Lorraine Forster as Senior Vice President of...
Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder
05 févr. 2024 08h00 HE
|
Hemex Health
A clinical study demonstrated high accuracy for Hemex Health's beta thalassemia test. It is the only beta thal test for point of care.
Point of Care Molecular Diagnostics Market Worth $5.38 Billion by 2028 - Exclusive Report by The Insight Partners
30 oct. 2023 05h27 HE
|
The Insight Partners
Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as...
HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic
15 sept. 2023 12h53 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is expanding its innovative point-of-care chronic...
Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track
30 août 2023 08h00 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to achieve significant growth, new partnerships and developing...
Avricore Health’s HealthTab™ Passes 530 Locations, Adds Virus Detection
23 mars 2023 10h46 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching...
Avricore Health Makes the Grade on 2023 TSX Venture 50
21 févr. 2023 10h00 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, Feb. 21, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) has been honoured by being named as one of the 2023 Venture 50, the TSX...
Avricore Health Reports Second-Quarter 2022 Results
29 août 2022 08h30 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s Q2 results. ...
Health Monitor Network® Appoints Key Sales Leader as Part of the Company’s Continued Growth Strategy
23 août 2022 09h00 HE
|
Health Monitor Network
Montvale, NJ, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Health Monitor Network®, a nationally recognized targeted healthcare marketing platform for the biopharmaceutical/OTC industry, today announced the...